Pulmatrix, Inc. (PULM) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1159515,
    "name": "Pulmatrix, Inc.",
    "stock_name": "Pulmatrix, Inc.",
    "full_name": "Pulmatrix, Inc.",
    "name_url": "stocks-analysis/pulmatrix-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "4.27",
    "chg": -0.16,
    "chgp": "-3.61%",
    "dir": -1,
    "prev_price": "4.43",
    "mcapval": "17.64",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "S&P 500",
    "isin": "US74584P3010",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "11.17 k",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/pulmatrix-inc-1159515-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is Pulmatrix, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-pulmatrix-inc-technically-bullish-or-bearish-3547529",
        "imagepath": "",
        "date": "2025-09-20 19:57:35",
        "description": "As of 28 August 2025, the technical trend for Pulmatrix, Inc. has changed from bearish to mildly bearish. The current stance is mildly bearish, driven primarily by the weekly MACD and Bollinger Bands indicating bearish signals, while the monthly indicators show a mildly bullish trend. The weekly RSI is bullish, but the daily moving averages are bearish, contributing to the overall mildly bearish outlook. \n\nIn terms of performance, the stock has underperformed the S&P 500 year-to-date with a return of -29.80% compared to the index's 12.22%, although it has significantly outperformed over the past year with a return of 131.13% versus the S&P 500's 17.14%...."
      },
      {
        "title": "Is Pulmatrix, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-pulmatrix-inc-overvalued-or-undervalued-3543867",
        "imagepath": "",
        "date": "2025-09-20 18:31:09",
        "description": "As of 6 August 2025, the valuation grade for Pulmatrix, Inc. has moved from risky to does not qualify, indicating a significant deterioration in its investment appeal. The company appears to be overvalued given its current financial metrics, including a Price to Book Value of 4.54 and negative ratios for EV to EBIT and EV to EBITDA at -2.54 and -2.59, respectively. Additionally, the Return on Equity (ROE) stands at a staggering -170.58%, further highlighting the company's struggles.\n\nIn comparison to its peers, Pulmatrix's valuation ratios are less favorable; for instance, Cyclerion Therapeutics, Inc. has an EV to EBITDA of -1.2082, while Sunshine Biopharma, Inc. shows a more manageable EV to EBITDA of 0.7084. The stock has had a mixed performance against the S&P 500, with a 1-year return of 131.13% compared to the index's 17.14%, but it has underperformed significantly year-to-date with a return of -29.80%..."
      }
    ],
    "total": 7,
    "sid": "1159515",
    "stock_news_url": "https://www.marketsmojo.com/news/pulmatrix-inc-1159515"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Is Pulmatrix, Inc. technically bullish or bearish?

2025-09-20 19:57:35

As of 28 August 2025, the technical trend for Pulmatrix, Inc. has changed from bearish to mildly bearish. The current stance is mildly bearish, driven primarily by the weekly MACD and Bollinger Bands indicating bearish signals, while the monthly indicators show a mildly bullish trend. The weekly RSI is bullish, but the daily moving averages are bearish, contributing to the overall mildly bearish outlook. In terms of performance, the stock has underperformed the S&P 500 year-to-date with a return of -29.80% compared to the index's 12.22%, although it has significantly outperformed over the past year with a return of 131.13% versus the S&P 500's 17.14%....

Is Pulmatrix, Inc. overvalued or undervalued?

2025-09-20 18:31:09

As of 6 August 2025, the valuation grade for Pulmatrix, Inc. has moved from risky to does not qualify, indicating a significant deterioration in its investment appeal. The company appears to be overvalued given its current financial metrics, including a Price to Book Value of 4.54 and negative ratios for EV to EBIT and EV to EBITDA at -2.54 and -2.59, respectively. Additionally, the Return on Equity (ROE) stands at a staggering -170.58%, further highlighting the company's struggles. In comparison to its peers, Pulmatrix's valuation ratios are less favorable; for instance, Cyclerion Therapeutics, Inc. has an EV to EBITDA of -1.2082, while Sunshine Biopharma, Inc. shows a more manageable EV to EBITDA of 0.7084. The stock has had a mixed performance against the S&P 500, with a 1-year return of 131.13% compared to the index's 17.14%, but it has underperformed significantly year-to-date with a return of -29.80%...

View All News